Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 509,790 | 489,735 | 470,252 | 487,267 | 668,210 |
| Cost of Goods | 399,957 | 393,655 | 367,896 | 374,767 | 495,579 |
| Gross Profit | 109,833 | 96,080 | 102,356 | 112,500 | 172,631 |
| Operating Expenses | 56,150 | 55,211 | 57,990 | 190,072 | 76,526 |
| Operating Income | 54,640 | 41,524 | 45,262 | -76,805 | 96,684 |
| Interest Expense | 13,430 | 11,570 | 9,152 | 14,372 | 14,690 |
| Pre-tax Income | 41,210 | 29,954 | 36,110 | -91,177 | 81,994 |
| Income Tax | 4,185 | 10,296 | 15,891 | 5,896 | -12,290 |
| Net Income Continuous | 37,025 | 19,658 | 20,219 | -97,073 | 94,284 |
| Net Income Discontinuous | N/A | N/A | N/A | -424 | 7,833 |
| Minority Interests | 350 | 205 | 492 | 140 | 134 |
| Net Income | $36,675 | $19,453 | $19,727 | $-97,637 | $101,983 |
| EPS Basic Total Ops | 0.79 | 0.42 | 0.44 | -2.20 | 2.30 |
| EPS Basic Continuous Ops | 0.79 | 0.42 | 0.44 | -2.18 | 2.13 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.01 | 0.17 |
| EPS Diluted Total Ops | 0.78 | 0.42 | 0.43 | -2.20 | 2.28 |
| EPS Diluted Continuous Ops | 0.78 | 0.42 | 0.43 | -2.18 | 2.11 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.01 | 0.17 |
| EPS Diluted Before Non-Recurring Items | 0.71 | 0.57 | 0.71 | 0.80 | 1.79 |
| EBITDA(a) | $70,424 | $58,685 | $63,778 | $-55,938 | $119,289 |